Ravinder Heights Ltd. (RVHL) — Tipsheet https://tipsheet.markets/company/rvhl/ Every Tipsheet Editorial note covering Ravinder Heights Ltd. (RVHL), newest first. Grounded in BSE/NSE primary-source filings. en-in Fri, 19 Jun 2026 11:12:16 GMT Serum Institute cuts Ravinder Heights stake by 2% in open market https://tipsheet.markets/rvhl-serum-institute-cuts-ravinder-heights-stake-by-2-in-open-market-109959/ https://tipsheet.markets/rvhl-serum-institute-cuts-ravinder-heights-stake-by-2-in-open-market-109959/ Fri, 19 Jun 2026 10:50:36 GMT The vaccine maker sold 1.27 million shares on June 16, lowering its holding from 9.39% to 7.32%. For a nano-cap real estate firm with collapsing revenue, a notable investor exit is a red flag. The vaccine maker sold 1.27 million shares on June 16, lowering its holding from 9.39% to 7.32%. For a nano-cap real estate firm with collapsing revenue, a notable investor exit is a red flag.

What’s new

  • Serum Institute sold 1.27 million shares (2.07%) of Ravinder Heights on June 16 via open market.
  • The sale reduces Serum's stake from 9.39% to 7.32% in the real estate company.
  • Disclosure under SEBI substantial acquisition norms; the exit exceeds 1% materiality threshold for nano-caps.

Why it matters

Serum Institute is not a passive financial investor; its stake reduction signals a deliberate portfolio shift. For Ravinder Heights, a ₹278 cr market-cap company with trailing revenue down 90.5%, losing a marquee stakeholder compounds the fundamental weakness. The stock will now carry a stigma that a long-term backer chose to leave.

What we’re watching

  • Whether Serum continues to sell further tranches in the coming weeks.
  • Any response from Ravinder Heights management; a buyback or promoter pledge could counter the signal.
  • Impact on stock liquidity and valuation multiples given the thin float.

The full read

Serum Institute of India sold 1.27 million shares ( 2.07% ) of Ravinder Heights on June 16. The open-market sale brings Serum's holding down to 7.32% from 9.39%, a notable reduction for a company with ₹278 cr market cap and trailing revenue that fell 90.5%. The stake, worth roughly ₹5.7 crore, exceeds the 1% materiality threshold for nano-caps, making the disclosure necessary. Ravinder Heights swung to a profit last year on one-time subsidiary revenue, but the core real estate business remains under pressure. When a shareholder of Serum's pedigree trims, the signal is hard to ignore.

Primary source: BSE · NSE

]]> Other Tipsheet Editorial Ravinder Heights swings to ₹49 cr profit on one-time subsidiary revenue https://tipsheet.markets/rvhl-ravinder-heights-swings-to-49-cr-profit-on-one-time-subsidiary-revenue-103783/ https://tipsheet.markets/rvhl-ravinder-heights-swings-to-49-cr-profit-on-one-time-subsidiary-revenue-103783/ Fri, 29 May 2026 20:35:50 GMT A real estate collaboration addendum drove the entire annual turnaround for a ₹240 crore market-cap company. The parent entity remains loss-making. A real estate collaboration addendum drove the entire annual turnaround for a ₹240 crore market-cap company. The parent entity remains loss-making.

What’s new

  • Ravinder Heights reported a ₹48.89 cr consolidated profit for FY26, erasing a ₹2.53 cr loss in FY25.
  • Annual revenue surged to ₹75.16 cr, driven by a collaboration addendum with Bestech India.
  • The parent entity remains loss-making, and Q4 posted a ₹2.94 cr net loss on negligible revenue.

Why it matters

The entire annual profit is a one-time windfall from a subsidiary's real estate settlement, not operational cash flow. For a company this size, the profit is large relative to market cap, but the core business isn't generating it.

What we’re watching

  • Whether the Radhika Heights subsidiary delivers any recurring revenue in FY27.
  • The standalone parent's path out of losses, separate from subsidiary settlements.
  • Any follow-up on the negligible Q4 operating revenue trend.

The full read

Ravinder Heights flipped from a ₹2.53 crore loss to a ₹48.89 crore profit in FY26. The entire swing is a one-time event: revenue recognition from a secondary addendum to a real estate collaboration agreement involving its subsidiary, Radhika Heights, and Bestech India. Annual revenue jumped to ₹75.16 crores on the back of this single settlement. The numbers are stark against the company's size: the profit alone is over 20% of its ₹240 crore market cap. But the core story is thin. The standalone parent is still loss-making. The fourth quarter was a ₹2.94 crore loss on negligible operating revenue, confirming the annual surge is settlement-driven, not operational. Total group equity strengthened to ₹289.92 crores, but the open question is what Ravinder Heights looks like without this one-off.

Primary source: BSE · NSE

]]> Earnings Tipsheet Editorial